Clinical Trial Update: Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control [Phase 4]

View source ↗

Summary

Phase 4 clinical trial (recruiting) evaluating the efficacy and safety of a metformin plus SGLT-2 inhibitor plus GLP-1 receptor agonist combination in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin + SGLT-2 inhibitor + GLP-1 receptor agonist (combination therapy)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 4 | Status: RECRUITING